SCHEMBL3320334

SCHEMBL3320334

COC(=O)Cc1cc(C(=O)O)c2cc(C(F)(F)F)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
USP2 O75604 1/20 0.42
CYP2C19 P33261 1/20 0.42
MRGPRX4 Q96LA9 2/20 0.40
SORT1 Q99523 4/20 0.40
LMNA P02545 2/20 0.40
CFTR P13569 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MPL P40238 1/20 0.40
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LIPC P11150 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
CSNK1D P48730 1/20 0.38
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2175522 0.85 HSP90AB1 (0.45) KDM4EALDH1A1LMNACFTRHSP90AB1
SCHEMBL2331533 0.83 HSP90AB1 (0.43) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL2334076 0.83 MEN1 (0.48) MRGPRX4HSP90AB1SMN1; SMN2CSNK1DDHODH
SCHEMBL11466806 0.80 LMNA (0.51) KDM4EALDH1A1HPGDLMNACFTR
SCHEMBL1296063 0.73 HSP90AB1 (0.56) ALDH1A1LMNAHSP90AB1MAPT
SCHEMBL841124 0.73 CYP4F2 (0.58) ALDH1A1LMNAHSP90AB1MAPTSMN1; SMN2
SCHEMBL31324171 0.72 KIF11 (0.51) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL5444853 0.72 PPARD (0.54) LMNAHSP90AB1
SCHEMBL1847657 0.71 ADORA3 (0.50) ALDH1A1HPGDLMNAHSP90AB1SMN1; SMN2
SCHEMBL30632615 0.71 HTT (0.60) ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2358677-B1 NAPHTHYLACETIC ACIDS USED AS CRTH2 ANTAGONISTS OR PARTIAL AGONISTS HOFFMANN LA ROCHE (CH) 2014-01-08 EP disclosed
US-8188090-B2 Naphthylacetic acids HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
CN-102216273-A Naphthylacetic acids used as crth2 antagonists or partial agonists HOFFMANN LA ROCHE (CH) 2011-10-12 CN disclosed
US-20100125061-A1 NAPHTHYLACETIC ACIDS FIROOZNIA FARIBORZ 2010-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100125061-A1 NAPHTHYLACETIC ACIDS HRH2, HRH1, HRH3 KDM4E 4285/4885ALDH1A1 1016/4885HPGD 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.